These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6322 related articles for article (PubMed ID: 3558118)

  • 41. Experimental pharmacology of auromomycin in L1210 tumor cells in vitro and in vivo.
    Samy TS; Siegel PJ; Hopper WE; Krishan A
    Cancer Res; 1984 Aug; 44(8):3202-7. PubMed ID: 6589039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines.
    Horwitz JP; Massova I; Wiese TE; Wozniak AJ; Corbett TH; Sebolt-Leopold JS; Capps DB; Leopold WR
    J Med Chem; 1993 Nov; 36(23):3511-6. PubMed ID: 8280289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New actinomycin D analogues as superior chemotherapeutic agents against primary and advanced colon tumors and colon xenografts in nude mice.
    Sengupta SK; Kogan Y; Kelly C; Szabo J
    J Med Chem; 1988 Apr; 31(4):768-74. PubMed ID: 3351854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antitumor activity of macromomycin].
    Kato T; Yamanaka N; Katayama S; Mizutani M; Ota K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1097-101. PubMed ID: 7184442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapy for mouse tumors and human tumor xenografts with the antitumor antibiotic AT-125.
    Houchens DP; Ovejera AA; Sheridan MA; Johnson RK; Bogden AE; Neil GL
    Cancer Treat Rep; 1979 Mar; 63(3):473-6. PubMed ID: 427827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of blood, ascites, and tumor cell density on cytocidal action of neocarzinostatin.
    Shimoyama M; Kimura K
    Gan; 1979 Apr; 70(2):165-71. PubMed ID: 157307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
    Mabel JA; Wodinsky I
    Cancer; 1983 Feb; 51(4):600-5. PubMed ID: 6401590
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumor activity of pyrindamycins A and B.
    Ishii S; Nagasawa M; Kariya Y; Yamamoto H; Inouye S; Kondo S
    J Antibiot (Tokyo); 1989 Nov; 42(11):1713-7. PubMed ID: 2531136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y
    Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
    Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
    Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU.
    Schabel FM; Trader MW; Laster WR; Shaddix SC; Brockman RW
    Cancer Treat Rep; 1976 Sep; 60(9):1325-33. PubMed ID: 1016968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice.
    Plowman J; Narayanan VL; Dykes D; Szarvasi E; Briet P; Yoder OC; Paull KD
    Cancer Treat Rep; 1986 May; 70(5):631-5. PubMed ID: 3708611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity.
    Sugawara K; Hatori M; Nishiyama Y; Tomita K; Kamei H; Konishi M; Oki T
    J Antibiot (Tokyo); 1990 Jan; 43(1):8-18. PubMed ID: 2106503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines.
    Tsuruo T; Oh-hara T; Iida H; Tsukagoshi S; Sato Z; Matsuda I; Iwasaki S; Okuda S; Shimizu F; Sasagawa K
    Cancer Res; 1986 Jan; 46(1):381-5. PubMed ID: 3753552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Spergualin, a new antitumor antibiotic].
    Takeuchi T
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):845-9. PubMed ID: 3566295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
    Dawson KM
    Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rodorubicin, a new tetraglycosidic anthracycline.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1988 Apr; (82):216-30. PubMed ID: 3165634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amphidinolide F, a new cytotoxic macrolide from the marine dinoflagellate Amphidinium sp.
    Kobayashi J; Tsuda M; Ishibashi M; Shigemori H; Yamasu T; Hirota H; Sasaki T
    J Antibiot (Tokyo); 1991 Nov; 44(11):1259-61. PubMed ID: 1761423
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of leukemia L1210 and P388 by arabinosylcytosine-polysaccharide conjugates.
    Novotný L; Balázová E; Sandula J; Ujházy V; Kéry V
    Int J Cancer; 1991 Jan; 47(2):281-4. PubMed ID: 1988371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 317.